Machine will diagnose cancer more accurately
NEW technology paid for by a local charity will mean diagnosing breast cancer at Derriford Hospital will be even more accurate.
The Primrose Breast Care Centre will be one of the first in the country to install the digital breast tomosythesis upgrade to one of the Siemens Mammomat Inspiration x-ray machines - meaning breast imagers will be able to see more clearly into the breast tissue.
Tomosynthesis is a three-dimensional imaging technique that has the potential of improving early detection of breast cancer and allows breast imagers to make more accurate diagnosis with fewer false alarms. The technique works particularly well for younger women and women with small cancers hidden in glandular tissues.
Dr Gareth Porter, Consultant Radiologist and Clinical Director of Imaging, said: "We are pleased to be one of the first trusts to support this new technology which will help us to improve the quality of the service we provide to our patients at a time we recognise can be very stressful.
Business Cards From Only £10.95 Delivered www.myprint-247.co.uk
View detailsOur heavyweight cards have FREE UV silk coating, FREE next day delivery & VAT included. Choose from 1000's of pre-designed templates or upload your own artwork. Orders dispatched within 24hrs.
Terms: Visit our site for more products: Business Cards, Compliment Slips, Letterheads, Leaflets, Postcards, Posters & much more. All items are free next day delivery. www.myprint-247.co.uk
Contact: 01858 468192
Valid until: Wednesday, May 22 2013
"Without the support of the Primrose Foundation we would not be in the fortunate position to develop the clinical research that will help shape future clinical practice further improving the care of women with breast problems."
The new technology has been paid for by The Primrose Foundation and is sponsored by Siemens.
Vince Golledge, regional sales and corporate business manager at Siemens, said: "Siemens was keen to support the Primrose Breast Unit in proving these benefits as part of a nationwide trial with other centres."
Comments